Yehoshua Levine, MD
Clinical Cardiac Electrophysiology · Memphis, TNNPI 1619136165
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Abbott at 29.9% of the total. Reporting peaked in 2020 at $14,194 and has fallen 91.3% since, to $1,234 in 2025.
Across 508 payments — averaging $72.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$11K
- Medtronic$10K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$7K
- Biosense Webster, Inc.$6K
- Bardy Diagnostics, Inc.$307
- Boston Scientific$267
- plus $1K from 9 others
Across 33 payments — averaging $2615.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$44K
- Abbott$42K
What the payments were for
- Consulting fees$3,48510%
- Speaking & faculty fees$17,48848%
- Travel & lodging$3,4359%
- Food & beverage$12,19833%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 132 | $10,959 |
| Medtronic(2 entities) | 144 | $10,113 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $7,458 |
| Biosense Webster, Inc. | 188 | $6,481 |
| Bardy Diagnostics, Inc. | 5 | $307 |
| Boston Scientific | 4 | $267 |
| Atricure, Inc. | 4 | $238 |
| Baxter Healthcare | 2 | $176 |
| Medicomp Inc | 2 | $148 |
| Philips North America LLC | 1 | $146 |
| Baylis Medical Company Inc | 3 | $118 |
| Johnson & Johnson(2 entities) | 5 | $110 |
| Pfizer | 2 | $45 |
| Irhythm Technologies, Inc. | 1 | $21 |
| Cardiva Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LifeVest$6,850
- Carto 3 System$3,485
- EnSite Precision Cardiac Mapping System$3,381
- Carto Smarttouch$2,700
- Carto CFAE$2,700
- CartoSound$2,700
- Ensite Cardiac Mapping System$2,125
- CARDIOMEMS$1,913
- Arctic Front$1,615
- PulseSelect$1,562
- ENSITE PRECISION$696
- Carto 3$541
- AMPLATZER AMULET$267
- ARCTIC FRONT ADVANCE$201
- QUADRA ASSURA$172
- Hillrom - Cardiac Ambulatory Monitor$147
- (9124) LM Undivided$146
- Quartet CRT Lead$136
- Micra$131
- Carnation Ambulatory Monitor$125
How this compares
$36,605 in reported general payments places this provider in the 80th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
See all clinical cardiac electrophysiology providers in Tennessee →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 275 | $251,225 |
| XareltoRivaroxaban | 144 | $141,068 |
| EntrestoSacubitril/Valsartan | 32 | $49,758 |
| FarxigaDapagliflozin Propanediol | 15 | $20,439 |
| Dofetilide | 42 | $1,475 |
| Amiodarone Hcl | 47 | $1,433 |
| SotalolSotalol Hcl | 64 | $1,285 |
| Metoprolol Succinate | 116 | $1,107 |
| Atorvastatin Calcium | 103 | $996 |
| Carvedilol | 86 | $910 |
| Potassium Chloride | 48 | $769 |
| Flecainide Acetate | 19 | $693 |
| Metoprolol Tartrate | 128 | $653 |
| Nebivolol Hcl | 17 | $605 |
| Losartan Potassium | 64 | $538 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $45 | $251,225275 claims |
| Johnson & JohnsonXarelto | $110 | $141,068144 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 82 clinical cardiac electrophysiology providers in Tennessee.
Other clinical cardiac electrophysiology in Memphis
- Ikechukwu IfediliMemphis$76K
- Indranill Basu RayMemphis$74K
- Eric JohnsonMemphis$59K
- Rajesh KabraMemphis$42K
- Sunil JhaMemphis$14K
- Karine GuerrierMemphis$7K
- Jeffrey KerlanMemphis$7K
- Stephen FahrigNashville$605K
- Gregory BashianNashville$361K
- Harish ManyamChattanooga$265K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.